Clinical activity, safety and predictive biomarkers results from a phase Ia atezolizumab (atezo) trial in extensive-stage small cell lung cancer (ES-SCLC)

Authors :: Jill Gilbert
Ariel Lopez-Chavez
Scott J. Antonia
Scott N. Gettinger
B. Liu
David S. Shames
Anne C. Chiang
Lecia V. Sequist
D. S. Thompson
Marcella Fassò
Paul Conkling
Carol O'Hear
Michael S. Gordon
J.P. Marcoux
Source :: Annals of Oncology. 27:vi493
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: 0301 basic medicine
Oncology
medicine.medical_specialty
Pathology
business.industry
Hematology
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Atezolizumab
030220 oncology & carcinogenesis
Internal medicine
medicine
business
Extensive-stage small cell lung cancer
Predictive biomarker

Full Text Access

Tools